Skip to content

Lung Open Ventilation to Decrease Mortality in the Acute Respiratory Distress Syndrome

A Randomized Trial of a Lung-Open Ventilation Strategy in Acute Lung Injury

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00182195
Acronym
LOVS
Enrollment
980
Registered
2005-09-16
Start date
2000-08-31
Completion date
2006-03-31
Last updated
2007-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Brief summary

A multinational, randomized trial comparing two lung protecting strategies of respiratory life support among critically ill patients with severe lung injury.

Detailed description

To compare an innovative Lung Open Ventilation strategy with a proven low tidal volume strategy, hypothesizing that the Lung Open Ventilation strategy may reduce mortality, other organ dysfunction, and the duration of mechanical ventilation, intensive care, and hospital stay.

Interventions

PROCEDUREControl Ventilation Strategy

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Invasive mechanical ventilation * Acute respiratory insufficiency (within past 28 days) * Bilateral infiltrates on frontal chest radiograph * Hypoxemia, defined as PaO2/FiO2\<=250

Exclusion criteria

* Primary cause of respiratory failure is cardiac * Anticipated duration of mechanical ventilation \< 48 hours * Inability to wean other experimental ventilation strategies * Severe chronic respiratory disease * Neuromuscular disease that will prolong mechanical ventilation * Conditions where hypercapnia-induced intracranial hypertension should be avoided * Morbid obesity (\> 1Kg per cm body weight) * Pregnancy * Very unlikely to survive and lack of commitment to life support Underlying irreversible condition with 6 month mortality \>= 50% * Greater than 48 hours elapsed since first eligible * Current participation in competing trial * Lack of physician, patient or proxy consent

Design outcomes

Primary

MeasureTime frame
Hospital Mortality

Secondary

MeasureTime frame
Mortality attributed to respiratory failure
Duration of respiratory failure and duration of mechanical failure
Evaluation of respiratory function during mechanical ventilation
Incidence of barotraumas
Non-respiratory organ dysfunction

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 6, 2026